BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16552002)

  • 1. Improved detection of metastatic melanoma by T2*-weighted imaging.
    Gaviani P; Mullins ME; Braga TA; Hedley-Whyte ET; Halpern EF; Schaefer PS; Henson JW
    AJNR Am J Neuroradiol; 2006 Mar; 27(3):605-8. PubMed ID: 16552002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracranial metastatic melanoma: correlation between MR imaging characteristics and melanin content.
    Isiklar I; Leeds NE; Fuller GN; Kumar AJ
    AJR Am J Roentgenol; 1995 Dec; 165(6):1503-12. PubMed ID: 7484597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated cerebral susceptibility artefacts in patients with malignant melanoma: metastasis or not?
    Gramsch C; Göricke SL; Behrens F; Zimmer L; Schadendorf D; Krasny A; Forsting M; Schlamann MU
    Eur Radiol; 2013 Sep; 23(9):2622-7. PubMed ID: 23670820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography and magnetic resonance imaging of nonhemorrhagic, metastatic melanoma of the brain--case report.
    Uozumi A; Saegusa T; Ohsato K; Yamaura A
    Neurol Med Chir (Tokyo); 1990 Feb; 30(2):143-6. PubMed ID: 1695337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral metastases from melanoma: findings on MR imaging.
    Premkumar A; Sanders L; Marincola F; Feuerstein I; Concepcion R; Schwartzentruber D
    AJR Am J Roentgenol; 1992 Feb; 158(2):293-8. PubMed ID: 1729784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant lesions of the liver with high signal intensity on T1-weighted MR images.
    Kelekis NL; Semelka RC; Woosley JT
    J Magn Reson Imaging; 1996; 6(2):291-4. PubMed ID: 9132092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Melanin Content and its Influence on Susceptibility Contrast in Melanoma Metastases.
    Straub S; Laun FB; Freitag MT; Kölsche C; von Deimling A; Denoix M; Bendszus M; Schlemmer HP; Ladd ME; Schneider TM
    Clin Neuroradiol; 2020 Sep; 30(3):607-614. PubMed ID: 31396654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative evaluation of computerized tomography/magnetic resonance (1.5 T) in the detection of brain metastasis].
    Golfieri R; Cherryman GR; Olliff JF; Husband JE
    Radiol Med; 1991; 82(1-2):27-34. PubMed ID: 1654578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma of the sinonasal cavity: explanation of magnetic resonance signal intensities with histopathologic characteristics.
    Kim SS; Han MH; Kim JE; Lee CH; Chung HW; Lee JS; Chang KH
    Am J Otolaryngol; 2000; 21(6):366-78. PubMed ID: 11115521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracerebral malignant melanoma: high-field-strength MR imaging.
    Woodruff WW; Djang WT; McLendon RE; Heinz ER; Voorhees DR
    Radiology; 1987 Oct; 165(1):209-13. PubMed ID: 3628773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma brain metastases: correlation of imaging features with genomic markers and patient survival.
    Bordia R; Zhong H; Lee J; Weiss S; Han SW; Osman I; Jain R
    J Neurooncol; 2017 Jan; 131(2):341-348. PubMed ID: 27822597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cystic amelanotic melanoma metastasis to the brain: case report.
    Cemil B; Emmez H; Oztanir N; Tokgoz N; Dogulu F
    Neurocirugia (Astur); 2008 Aug; 19(4):365-7. PubMed ID: 18726049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal intensity of brain metastases on T2-weighted images: specificity for metastases from colonic cancers.
    Suzuki M; Takashima T; Kadoya M; Ueda T; Arakawa F; Ueda F; Yamashita J; Yamashima T; Nonomura A
    Neurochirurgia (Stuttg); 1993 Sep; 36(5):151-5. PubMed ID: 8272166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral MR imaging of malignant melanoma].
    Breckwoldt M; Bendszus M
    Radiologe; 2015 Feb; 55(2):113-9. PubMed ID: 25589420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variety of appearances of malignant melanoma in the head: a review.
    Escott EJ
    Radiographics; 2001; 21(3):625-39. PubMed ID: 11353111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility-weighted imaging in malignant melanoma brain metastasis.
    Schwarz D; Niederle T; Münch P; Hielscher T; Hassel JC; Schlemmer HP; Platten M; Winkler F; Wick W; Heiland S; Delorme S; Bendszus M; Bäumer P; Breckwoldt MO
    J Magn Reson Imaging; 2019 Oct; 50(4):1251-1259. PubMed ID: 30793419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
    Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
    AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Susceptibility-Weighted Imaging (SWI) in the Detection of Brain Hemorrhagic Metastases from Breast Cancer and Melanoma.
    Franceschi AM; Moschos SJ; Anders CK; Glaubiger S; Collichio FA; Lee CB; Castillo M; Lee YZ
    J Comput Assist Tomogr; 2016; 40(5):803-5. PubMed ID: 27636126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perilesional Hyperintensity on T1-Weighted Images in Intra-Axial Brain Masses other than Cavernous Malformations.
    Nabavizadeh SA; Pechersky D; Schmitt JE; Nasrallah M; Wolf R; Loevner L; Mamourian AC
    J Neuroimaging; 2017 Sep; 27(5):531-538. PubMed ID: 28098958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance imaging features in melanoma.
    Marx HF; Colletti PM; Raval JK; Boswell WD; Zee CS
    Magn Reson Imaging; 1990; 8(3):223-9. PubMed ID: 2366635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.